What is the definition, etiology, and clinical presentation of acute kidney injury?

Acute Kidney Injury: Definition, Etiology, and Clinical Presentation

Acute kidney injury (AKI) is defined by the KDIGO criteria as any of the following: serum creatinine rise ≥0.3 mg/dl (≥26 μmol/l) within 48 hours, OR serum creatinine increase to ≥1.5 times baseline within 7 days, OR urine output <0.5 ml/kg/h for 6 hours 1.

Definition and Staging

AKI is a syndrome characterized by rapid loss of kidney excretory function, resulting in accumulation of nitrogenous waste products and disturbances in fluid, electrolyte, and acid-base balance 1. The KDIGO staging system stratifies severity into three stages based on both creatinine and urine output criteria:

Stage 1:

• Creatinine: Rise of ≥26 μmol/l (0.3 mg/dl) within 48h OR 1.5-1.99× baseline within 7 days
• Urine output: <0.5 ml/kg/h for >6 hours

Stage 2:

• Creatinine: 2.0-2.99× baseline within 7 days
• Urine output: <0.5 ml/kg/h for >12 hours

Stage 3:

• Creatinine: ≥3.0× baseline OR ≥354 μmol/l (4.0 mg/dl) OR initiation of renal replacement therapy
• Urine output: <0.3 ml/kg/h for 24 hours OR anuria for 12 hours 1

This unified definition emerged from combining the RIFLE and AKIN criteria, ensuring comprehensive capture of AKI cases that might be missed by either classification alone 2.

Etiology

AKI has multiple causes that are traditionally categorized into three pathophysiologic mechanisms:

Prerenal AKI (Hypoperfusion)

• Volume depletion (hemorrhage, gastrointestinal losses, burns)
• Decreased cardiac output (heart failure, myocardial infarction)
• Systemic vasodilation (sepsis, anaphylaxis, medications)
• Renal vasoconstriction (NSAIDs, ACE inhibitors, hepatorenal syndrome)

Intrinsic Renal AKI

• Acute tubular necrosis (most common): Ischemic injury or nephrotoxic exposure (aminoglycosides, contrast media, chemotherapy agents)
• Acute interstitial nephritis: Drug-induced (antibiotics, PPIs, NSAIDs), autoimmune
• Glomerulonephritis: Rapidly progressive GN, lupus nephritis
• Vascular: Renal artery/vein thrombosis, vasculitis, malignant hypertension

Postrenal AKI (Obstruction)

• Urethral obstruction (prostatic hypertrophy, malignancy)
• Bilateral ureteral obstruction (stones, retroperitoneal fibrosis, malignancy)
• Bladder outlet obstruction (neurogenic bladder, blood clots)

3, 4, 5

Critical point: In hospitalized patients, particularly those in intensive care, AKI is predominantly multifactorial. The most common precipitants are sepsis, major surgery, and nephrotoxic drug exposure 4. AKI is not simply a consequence of comorbidities but independently contributes to mortality—patients die "from AKI" not just "with AKI" 1.

Clinical Presentation and Symptoms

AKI is frequently asymptomatic in early stages and detected only through laboratory monitoring 6. When symptoms occur, they reflect:

Direct Renal Manifestations

• Oliguria or anuria (though non-oliguric AKI is common)
• Flank pain (suggests obstruction, renal infarction, or pyelonephritis)
• Hematuria (glomerulonephritis, vasculitis)

Uremic Symptoms (Advanced AKI)

• Nausea, vomiting, anorexia
• Altered mental status, confusion, lethargy
• Pruritus
• Metallic taste

Volume Overload Signs

• Peripheral edema
• Pulmonary edema (dyspnea, orthopnea)
• Hypertension
• Jugular venous distension

Electrolyte and Metabolic Derangements

• Hyperkalemia (muscle weakness, cardiac arrhythmias)
• Metabolic acidosis (Kussmaul respirations)
• Hypocalcemia (tetany, seizures)
• Hyperphosphatemia

Systemic Illness Features

• Fever (sepsis, acute interstitial nephritis)
• Rash (drug reaction, vasculitis, atheroembolic disease)
• Hypotension or shock (prerenal causes)
• Signs of underlying disease (heart failure, liver disease)

7, 6, 5

Critical Diagnostic Considerations

A common pitfall is that serum creatinine is a concentration marker affected by volume status 2. In patients receiving aggressive fluid resuscitation, dilutional effects may mask significant GFR reduction, causing AKI to be underdiagnosed when using creatinine criteria alone. Conversely, volume depletion may elevate creatinine without true kidney injury. This is why the KDIGO definition incorporates both creatinine and urine output criteria.

The clinical history must specifically identify:

• Nephrotoxic medication exposure (NSAIDs, aminoglycosides, contrast agents, chemotherapy)
• Recent procedures or surgeries
• Volume losses or hemodynamic instability
• Symptoms of urinary obstruction (hesitancy, decreased stream in older men)
• Systemic illness suggesting glomerulonephritis or vasculitis

Physical examination priorities:

• Intravascular volume assessment (orthostatic vital signs, mucous membranes, skin turgor, jugular venous pressure)
• Bladder distension (suggests obstruction)
• Skin findings (rash, livedo reticularis, purpura)

2, 5

The prognostic significance of AKI extends beyond the acute episode—even mild AKI (Stage 1) is independently associated with approximately fourfold increased hospital mortality and substantially elevated risk of progression to chronic kidney disease 1, 8.